$2.1MRound, 18 May 2026
Kotak Life Sciences Fund I invests ₹20 Cr to advance CAR-T clinical programs, gene therapy pipeline and GMP manufacturing.
- Amount
- $2.1M
- Announced
- 18 May 2026
- Lead
- Kotak Alts
- Use of funds
- Kotak Life Sciences Fund I invests ₹20 Cr to advance CAR-T clinical programs, gene therapy pipeline and GMP manufacturing.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Cellogen Therapeutics raises ₹20 Cr from Kotak Alts inc42.com
Cellogen Therapeutics raises ₹20 Cr from Kotak Alts bfsi.economictimes.indiatimes.com